U.S. Patents Awarded to Inventors in Washington (Jan. 5)

(Targeted News Service Via Acquire Media NewsEdge) Targeted News Service Targeted News Service ALEXANDRIA, Va., Jan. 5 -- The following federal patents were awarded to inventors in Washington.

*** Cardiac Pacemakers Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Cardiac Pacemakers, St. Paul, Minn., has been assigned a patent (8,343,064) developed by Gust H. Bardy, Seattle, for a "system and method for diagnosing and monitoring congestive heart failure." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A system and method for providing diagnosis and monitoring of congestive heart failure for use in automated patient care is described. At least one recorded physiological measure is compared to at least one other recorded physiological measure on a substantially regular basis to quantify a change in patient pathophysiological status for equivalent patient information. An absence, an onset, a progression, a regression, and a status quo of congestive heart failure is evaluated dependent upon the change in patient pathophysiological status." The patent application was filed on May 25, 2011 (13/115,266). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,343,064&OS=8,343,064&RS=8,343,064 Written by Neha Bharti; edited by Jaya Anand.

*** Homax Products Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Homax Products, Bellingham, Wash., has been assigned a patent (8,344,056) developed by four co-inventors for "aerosol dispensing systems, methods, and compositions for repairing interior structure surfaces." The co-inventors are William Stephen Tait, Madison, Wis., John Kordosh, Simi Valley, Calif., Steve Moore, Acworth, Ga., and Randy Hanson, Bellingham, Wash.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method of covering an anomaly in a wall substantially to match a pre-existing texture pattern surrounding the anomaly. The method comprises the following steps. A valve is supported on a container assembly to define a main chamber. Contained material comprising wall material concentrate and propellant material is disposed within the main chamber. An actuator relative is arranged relative to the container assembly such that displacement of a button relative to the valve changes the valve from a closed configuration to an open configuration in which a portion of the propellant material is allowed to force the contained material out of the main chamber through the outlet. A first portion of the contained material is applied to the anomaly by directing the outlet at the anomaly and displacing the button. Optionally, a second portion of the contained material may be applied to the base coat by directing the outlet at the base coat and displacing the button. If applied, the second portion of the contained material forms a desired texture pattern on the base coat that substantially matches the pre-existing texture pattern." The patent application was filed on March 1, 2010 (12/715,228). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,344,056&OS=8,344,056&RS=8,344,056 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Merck Sharp & Dohme Assigned Patent for IGF-1R Specific Antibodies Useful in the Detection and Diagnosis of Cellular Proliferative Disorders ALEXANDRIA, Va., Jan. 5 -- Merck Sharp & Dohme, Rahway, N.J., has been assigned a patent (8,344,112) developed by five co-inventors for "IGF-1R specific antibodies useful in the detection and diagnosis of cellular proliferative disorders." The co-inventors are Liliane Goetsch, Ayze, France, David Brooks, Concord, Mass., Michael Chastain, Seattle, Zhi-Qiang Zhang, Lansdale, Pa., and Nathalie Corvaia, Collonges sous Saleve, France.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention relates to mammalian antibodies, designated 12B1 and antigen-binding portions thereof that specifically bind to insulin-like growth factor I receptor (IGF-IR), preferably human IGF-IR. Also included are chimeric, bispecific, derivatized, single chain antibodies derived from the antibodies disclosed herein. Nucleic acid molecules encoding the mammalian antibodies as well as methods of use thereof are also disclosed. Also included are pharmaceutical compositions comprising these antibodies and methods of using the antibodies and compositions thereof for treatment and diagnosis of pathological hyperproliferative oncogenic disorders associated with expression of IGF-1R." The patent application was filed on July 25, 2008 (12/670,863). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,344,112&OS=8,344,112&RS=8,344,112 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** LipoSonix Assigned Patent ALEXANDRIA, Va., Jan. 5 -- LipoSonix, Hayward, Calif., has been assigned a patent (8,343,051) developed by Charles S. Desilets, Mukilteo, Wash., and Cameron Pollock, Sammamish, Wash., for an "apparatus and methods for the destruction of adipose tissue." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Methods and apparatus are described for modifying unwanted tissue for cosmetic reasons. The methods provide a non-invasive manner to perform body contouring by destroying adipose tissue while simultaneously causing collagen contraction in a single procedure so that as destroyed tissue is removed from a treatment volume, the volume shrinks gradually to maintain the skin tone of the treatment area. The procedure may involve multiple treatments to the same treatment area or location." The patent application was filed on Sept. 14, 2009 (12/559,239). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,343,051&OS=8,343,051&RS=8,343,051 Written by Neha Bharti; edited by Jaya Anand.

*** Physio-Control Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Physio-Control, Redmond, Wash., has been assigned a patent (8,343,081) developed by Rob Walker, Bothell, Wash., for a "mechanical CPR device with variable resuscitation protocol." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Methods to control the delivery of CPR to a patient through a mechanical CPR device are described. The method generally allows for a gradual increase in the frequency of CPR cycles. The gradual increase can be regulated by protocols programmed within the CPR device such as intermittently starting and stopping the delivery of CPR, accelerating the delivery of CPR, stepping up the CPR frequency, increasing the force of CPR, and adjusting the ratio of compression and decompression in a CPR cycle. Combinations of each of these forms may also be used to control the delivery of CPR. This manner of gradually accelerating artificial blood flow during the first minutes of mechanical CPR delivery can serve to lessen the potential for ischemia/reperfusion injury in the patient who receives mechanical CPR treatment." The patent application was filed on Dec. 20, 2007 (11/961,687). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,343,081&OS=8,343,081&RS=8,343,081 Written by Neha Bharti; edited by Jaya Anand.

*** Siemens Medical Solutions USA Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Siemens Medical Solutions USA, Malvern, Pa., has been assigned a patent (8,343,050) developed by Liexiang Fan, Sammamish, Wash., and Kevin Sekins, Yallow Point, Wash., for "feedback in medical ultrasound imaging for high intensity focused ultrasound." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Feedback of position is provided for high intensity focused ultrasound. The location of a beam from a HIFU transducer is determined using ultrasound imaging. The ultrasound imaging detects tissue displacement caused by a beam transmitted from the HIFU transducer. The displacement or information derived from the displacement may be used to detect and image the location of the beam. Separate transducers may be used for HIFU and imaging. The user aims the HIFU transmissions with feedback from ultrasound imaging of displacement of tissue." The patent application was filed on May 4, 2009 (12/435,196). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,343,050&OS=8,343,050&RS=8,343,050 Written by Neha Bharti; edited by Jaya Anand.

*** University of Iowa Assigned Patent ALEXANDRIA, Va., Jan. 5 -- The University of Iowa, Iowa City, Iowa, has been assigned a patent (8,343,911) developed by Pradeep K. Singh, Iowa City, Iowa, Michael J. Welsh, Riverside, Iowa, and E. Peter Greenberg, Seattle, for "methods of inhibiting and treating bacterial biofilms by metal chelators." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The invention presented herein provides methods and compositions for the prevention and treatment of bacterial infections. The methods are based on the discovery that depletion of bioavailable iron stimulates surface motility in bacteria thus inhibiting the ability of a bacterial population to develop into a biofilm." The patent application was filed on Oct. 20, 2008 (12/288,449). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,343,911&OS=8,343,911&RS=8,343,911 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** University of Utah Assigned Patent ALEXANDRIA, Va., Jan. 5 -- The University of Utah, Salt Lake City, has been assigned a patent (8,343,942) developed by four co-inventors for "methods for treating interstitial cystitis." The co-inventors are Siam Oottamasathien, Salt Lake City, Wanjian Jia, Salt Lake City, Glenn D. Prestwich, Eastsound, Wash., and Lindsi McCoard, Salt Lake City.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Described herein are methods for treating interstitial cystitis in a subject comprising administering to the subject an effective amount of a compound which is a modified hyaluronan or a pharmaceutically acceptable salt or ester thereof, wherein said hyaluronan or its pharmaceutically acceptable salt or ester comprises at least one sulfate group and the primary C-6 hydroxyl proton of at least one N-acetyl-glucosamine residue is substituted with an unsubstituted alkyl group or fluoroalkyl group." The patent application was filed on March 23, 2011 (13/069,860). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,343,942&OS=8,343,942&RS=8,343,942 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Omeros Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Omeros, Seattle, has been assigned a patent (8,343,970) developed by four co-inventors for "PDE10 inhibitors and related compositions and methods." The co-inventors are Neil S. Cutshall, Snohomish, Wash., Jennifer Lynn Gage, Kenmore, Wash., Thomas Neil Wheeler, Raleigh, N.C., and Thomas L. Little, Redmond, Wash.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Compounds that inhibit PDE10 are disclosed that have utility in the treatment of a variety of conditions, including (but not limited to) psychotic, anxiety, movement disorders and/or neurological disorders such as Parkinson's disease, Huntington's disease, Alzheimer's disease, encephalitis, phobias, epilepsy, aphasia, Bell's palsy, cerebral palsy, sleep disorders, pain, Tourette's syndrome, schizophrenia, delusional disorders, drug-induced psychosis and panic and obsessive-compulsive disorders. Pharmaceutically acceptable salts, stereoisomers, solvates and prodrugs of the compounds are also provided. Also disclosed are compositions containing a compound in combination with a pharmaceutically acceptable carrier, as well as methods relating to the use thereof for inhibiting PDE10 in a warm-blooded animal in need of the same." The patent application was filed on March 10, 2011 (13/045,162). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,343,970&OS=8,343,970&RS=8,343,970 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Seattle Genetics Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Seattle Genetics, Bothell, Wash., has been assigned a patent (8,343,928) developed by Svetlana O. Doronina, Snohomish, Wash., and Toni Beth Kline, Seattle, for "monomethylvaline compounds having phenylalanine side-chain replacements at the C-terminus." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Auristatin peptide analogs of MeVal-Val-Dil-Dap-Phe (MMAF) are provided having C-terminal phenylalanine residue side chain replacements or modifications which are provided alone or attached to ligands through various linkers. The related conjugates can target specific cell types to provide therapeutic benefit." The patent application was filed on July 7, 2006 (11/994,809). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,343,928&OS=8,343,928&RS=8,343,928 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Physio-Control Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Physio-Control, Redmond, Wash., has been assigned a patent (8,344,899) developed by Joseph L. Sullivan, Kirkland, Wash., Benjamin A. Flugstad, Port Ludlow, Wash., and Glenn Morita, Lynnwood, Wash., for a "power conserving alert for medical devices." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Techniques are provided for alerting a person to check a medical device while conserving battery power. The medical device initiates a status alert if a readiness condition of the medical device is no longer being met. The status alert includes notification periods during which an audible sound is emitted alternating with off periods during which substantially no audible sound is emitted. The audible sounds may include certain tones or at least one spoken word. At least one of the duration of successive notification periods or the duration of successive off periods may be varied. In this manner, the medical device may provide audible sound at different times during the day in an attempt to get the attention of a person. In addition, the medical device may sense an activity to determine when to provide the audible sound." The patent application was filed on Oct. 4, 2010 (12/897,042). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,344,899.PN.&OS=PN/8,344,899&RS=PN/8,344,899 Written by Kusum Sangma; edited by Anand Kumar.

*** Impinj Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Impinj, Seattle, has been assigned a patent (8,344,857) developed by Ronald A. Oliver, Seattle, John D. Hyde, Corvallis, Wash., and Charles J. T. Peach, Seattle, for an "RFID tags with synchronous power rectifier." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present disclosure provides a power rectifier for a Radio Frequency Identification tag circuit. The rectifier is constructed from a pair of complementary MOS transistors. Gates of the transistors have predetermined voltages applied to them. The applied voltages bias the transistors to near their active operating region. During the same time additional control signals are applied to the gates of the transistors, the control signals are synchronous, but out of phase, with each other." The patent application was filed on Nov. 30, 2011 (13/307,098). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,344,857.PN.&OS=PN/8,344,857&RS=PN/8,344,857 Written by Kusum Sangma; edited by Anand Kumar.

*** Boeing Assigned Patent for Wireless Aircraft Sensor Network ALEXANDRIA, Va., Jan. 5 -- Boeing, Chicago, has been assigned a patent (8,344,912) developed by Bradley J. Mitchell, Snohomish, Wash., and Edwin C. Lim, Woodinville, Wash., for a "wireless aircraft sensor network." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method and apparatus in a sensor network in an aircraft for collecting data about the aircraft. The sensor network in the aircraft collects the data about the aircraft. The sensor network comprises a set of wireless sensors attached to a first set of locations for the aircraft, a set of wireless routers attached to a second set of locations for the aircraft, and a set of gateways connected to an aircraft data processing system. The set of wireless routers is capable of receiving the data in wireless signals transmitted by the set of wireless sensors. The set of gateways is capable of receiving data in the wireless signals from the set of wireless routers to form received data and is capable of transmitting the received data into the aircraft data processing system." The patent application was filed on April 25, 2011 (13/093,605). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,344,912.PN.&OS=PN/8,344,912&RS=PN/8,344,912 Written by Kusum Sangma; edited by Anand Kumar.

*** Novozymes Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Novozymes, Davis, Calif., has been assigned a patent (8,343,767) developed by Paul Harris, Carnation, Wash., and Howard Brody, Davis, Calif., for "methods for increasing homologous recombination of a nucleic acid sequences." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention relates to methods for increasing homologous recombination of a nucleic acid sequence introduced into a host cell, comprising: (a) introducing into a population of filamentous fungal host cells a first nucleic acid sequence encoding a recombination protein and a second nucleic acid sequence comprising one or more regions which are homologous with the genome of the filamentous fungal host cell, wherein (i) the recombination protein promotes the recombination of the one or more regions with the corresponding homologous region in the host's genome to incorporate the second nucleic acid sequence by homologous recombination, and (ii) the number of host cells comprising the incorporated second nucleic acid sequence in the population is increased at least 20% compared to the same population without the first nucleic acid sequence; (b) and isolating from the population a filamentous fungal cell comprising the incorporated second nucleic acid sequence." The patent application was filed on March 29, 2012 (13/434,694). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,343,767.PN.&OS=PN/8,343,767&RS=PN/8,343,767 Written by Kusum Sangma; edited by Anand Kumar.

*** Sharp Laboratories of America Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Sharp Laboratories of America, Camas, Wash., has been assigned a patent (8,344,917) developed by Kiran Misra, Vancouver, Wash., and Christopher A. Segall, Camas, Wash., for "methods and systems for context initialization in video coding and decoding." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Aspects of the present invention are related to systems and methods for context model initialization in entropy encoders and decoders." The patent application was filed on Sept. 30, 2010 (12/895,676). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,344,917.PN.&OS=PN/8,344,917&RS=PN/8,344,917 Written by Kusum Sangma; edited by Anand Kumar.

*** Boeing Assigned Patent for Aircraft Cabin Noise Exposure Analysis ALEXANDRIA, Va., Jan. 5 -- Boeing, Chicago, has been assigned a patent (8,344,910) developed by Zhennong Wang, Renton, Wash., for an "aircraft cabin noise exposure analysis." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Systems and methods for aircraft cabin noise analysis are disclosed. In one embodiment, a method includes receiving a first request for an aircraft cabin noise analysis, wherein the request comprises a plurality of flight parameters associated with a first flight mission, retrieving, from a computer readable memory, a plurality of noise parameters associated with the plurality of flight parameters for the first flight mission, determining a total noise exposure parameter associated with the first flight mission, generating an output comprising the total noise exposure on a user interface, and generating a warning on a user interface when the total noise exposure exceeds a threshold. In some embodiments, the monitored system may be implemented in a computing system or as logic instructions recorded on a computer readable medium." The patent application was filed on Aug. 18, 2009 (12/543,402). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,344,910.PN.&OS=PN/8,344,910&RS=PN/8,344,910 Written by Kusum Sangma; edited by Anand Kumar.

*** Boeing Assigned Patent for Integrated Circulator for Phased Arrays ALEXANDRIA, Va., Jan. 5 -- Boeing, Chicago, has been assigned a patent (8,344,820) developed by Ming Chen, Bellevue, Wash., and Jimmy S. Takeuchi, Mercer Island, Wash., for an "integrated circulator for phased arrays." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A circulator/isolator assembly is disclosed. The assembly includes a first magnetic substrate having first surface and a second surface and a first ground plane formed on the first surface. A dielectric layer is disposed adjacent first magnetic substrate. The dielectric layer includes a multi-port junction circuit coupled to transmission traces. One of the traces forms an input port and another forms an output port. A first magnet is disposed proximate the multi-port junction circuit of the dielectric layer. The first magnet excites a circular, unidirectional magnetic flux field in the first magnetic substrate that limits electromagnetic wave propagation to a single direction." The patent application was filed on Jan. 17, 2011 (13/007,947). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,344,820.PN.&OS=PN/8,344,820&RS=PN/8,344,820 Written by Kusum Sangma; edited by Anand Kumar.

For more information about Targeted News Service products and services, please contact: Myron Struck, editor, Targeted News Service LLC, Springfield, Va., 703/304-1897; editor@targetednews.com; http://targetednews.com.

-1110075 (c) 2013 Targeted News Service

[ Back To Technology News's Homepage ]